Your browser doesn't support javascript.
loading
Physiologically based pharmacokinetic model analysis of the inhibitory effect of vonoprazan on the metabolic activation of proguanil.
Okubo, Kenjiro; Kudo, Toshiyuki; Yoshihara, Sae; Nakabayashi, Yu; Nakauchi, Kana; Tanaka, Akimi; Saito, Moe; Tsujisawa, Ayumi; Goda, Hitomi; Yamagishi, Yoshiaki; Otake, Chinatsu; Makino, Kosho; Takahashi, Hideyo; Ito, Kiyomi.
Afiliação
  • Okubo K; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Kudo T; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan; Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan. Electronic address: to_kudou@musashino-u.ac.jp.
  • Yoshihara S; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Nakabayashi Y; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Nakauchi K; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Tanaka A; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Saito M; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Tsujisawa A; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Goda H; Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan.
  • Yamagishi Y; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan; Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan. Electronic address: y_yama@musashino-u.ac.jp.
  • Otake C; Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba, 278-8510, Japan.
  • Makino K; Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba, 278-8510, Japan. Electronic address: k-makino@musashino-u.ac.jp.
  • Takahashi H; Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba, 278-8510, Japan. Electronic address: hide-tak@rs.tus.ac.jp.
  • Ito K; Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan; Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan. Electronic address: k-ito@musashino-u.ac.jp.
Drug Metab Pharmacokinet ; 54: 100537, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38086197

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Sulfonamidas / Triazinas / Proguanil Limite: Adult / Humans Idioma: En Revista: Drug Metab Pharmacokinet Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Sulfonamidas / Triazinas / Proguanil Limite: Adult / Humans Idioma: En Revista: Drug Metab Pharmacokinet Ano de publicação: 2024 Tipo de documento: Article